B-Cell Activating Factor Predicts Acute Rejection Risk in Kidney Transplant Recipients: A 6-Month Follow-Up Study

B cell activating factor (BAFF) belonging to TNF family is a cytokine that enhances B-cell proliferation and differentiation. Recently, It has been suggested that BAFF might be a potential therapeutic target for treating autoimmune disease. However, the relationship between BAFF and allograft reject...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xu-Zhen, Wan, Zhen, Xue, Wu-Jun, Zheng, Jin, Li, Yang, Ding, Chen Guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529956/
https://www.ncbi.nlm.nih.gov/pubmed/31156628
http://dx.doi.org/10.3389/fimmu.2019.01046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529956/
https://www.ncbi.nlm.nih.gov/pubmed/31156628
http://dx.doi.org/10.3389/fimmu.2019.01046

Ejemplares similares